Dina Hansen, DPM
Foot & Ankle Surgery · West Palm Beach, FLNPI 1326421280
Payments from drug & device makers
Across 158 payments — averaging $61.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organogenesis Inc.$4K
- Integra Lifesciences Corporation$2K
- Abbott$801
- Smith+Nephew$550
- Stryker$451
- Treace Medical Concepts, Inc.$291
- plus $1K from 23 others
What the payments were for
- Consulting fees$3,60037%
- Travel & lodging$3063%
- Food & beverage$5,74960%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organogenesis Inc. | 52 | $4,143 |
| Integra Lifesciences Corporation | 26 | $2,100 |
| Abbott | 9 | $801 |
| Smith+Nephew | 19 | $550 |
| Stryker | 8 | $451 |
| Treace Medical Concepts, Inc. | 9 | $291 |
| Boston Scientific | 3 | $219 |
| Acera Surgical, Inc. | 6 | $191 |
| Medtronic | 2 | $128 |
| Novo Nordisk | 1 | $124 |
| Boehringer Ingelheim | 1 | $114 |
| DJO, LLC | 1 | $82 |
| Ossio Inc | 1 | $64 |
| Southern Edge Orthopaedics, Inc. | 1 | $47 |
| Melinta Therapeutics, LLC | 2 | $44 |
| AbbVie | 2 | $43 |
| Reprise Biomedical, Inc. | 2 | $38 |
| Solventum Corporation | 1 | $28 |
| Ossdsign USA Incorporated | 2 | $24 |
| Kowa Pharmaceuticals America, Inc. | 1 | $22 |
| Triad Life Sciences Inc. | 1 | $21 |
| KCI USA, Inc. | 1 | $20 |
| Aroa Biosurgery Incorporated | 1 | $19 |
| Amgen | 1 | $18 |
| Bioventus LLC | 1 | $16 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
| Exact Sciences | 1 | $14 |
| Misonix Inc | 1 | $13 |
| Zimmer Biomet | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PuraPly$2,636
- CODMAN CERTAS$1,200
- DURASEAL EXACT$1,200
- CODMAN HAKIM PRECISION VALVE$1,200
- CUSA CLARITY$1,200
- Supera peripheral stent system$399
- Apligraf$355
- INTEGRA MESHED BILAYER WOUND MATRIX$142
- INTEGRA DERMAL REGENERATION TEMPLATE$142
- INTEGRA FLOWABLE WOUND MATRIX$142
- Perclose ProGlide suture mediated closure system$139
- GrafixPL$125
- Stravix$125
- GENERAL VASCULAR INTERVENTION$125
- Wegovy$124
- PURAPLY WOUND MATRIX$121
- Affinity$121
- JARDIANCE$114
- HawkOne$110
- FREESTYLE LIBRE 3$104
How this compares
$9,655 in reported general payments places this provider in the 75th percentile of 850 foot & ankle surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SantylCollagenase Clostridium Hist. | 34 | $17,028 |
| Gentamicin Sulfate | 101 | $4,488 |
| Diclofenac Sodium | 67 | $2,005 |
| Ciclopirox | 67 | $1,920 |
| Ammonium Lactate | 123 | $1,846 |
| Clotrimazole | 86 | $1,591 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 39 | $909 |
| Mupirocin | 84 | $653 |
| Ketoconazole | 17 | $362 |
| Gabapentin | 48 | $300 |
| Triamcinolone Acetonide | 17 | $135 |
| Ciprofloxacin Hcl | 15 | $109 |
| Cephalexin | 21 | $89 |
| Meloxicam | 44 | $70 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Smith+NephewSantyl | $550 | $17,02834 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 850 foot & ankle surgery providers in Florida.
Other foot & ankle surgery in West Palm Beach
- Bradley LammWest Palm Beach$938K
- Thomas SangiovanniCoral Gables$2.1M
- Shayne JensenPanama City$1.3M
- Thomas RoukisOrlando$1.1M
- Craig BreslauerStuart$971K
- Amber ShaneOrlando$830K
- Jonathan BlumKissimmee$814K
- Riquel GonzalezHialeah$612K
- Mario CalaHialeah$544K
- Christopher ReevesLake Mary$437K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.